Anticancerdrugs

Enzamide 40MG Enzamide 40mg  is a non steroidal anti-androgen drug; by inhibiting the androgen synthesis and expels anti-neoplastic activity against prostate tumor. Enzamide 40mg is an oral tablet form, which is endorsed by FDA. Enzalutamide is related with a reducing rate of serum enzyme increased during treatment, be that as it may, have not been connected to instances of clinically clear liver damage with jaundice. Enzalutamide Mechanism of action Androgen is a male hormone; testosterone is a one of the hormone secreted from androgen which is responsible for growth of the tumor cells present in the prostate glands.  Enzamide  40 mg tablets are comprises of  Enzalutamide  which acts by inhibiting the binding of androgen into androgen receptor site. This inhibition leads to interfere with signal transduction of receptors and causes growth retardation. The active metabolite of Enzalutamide is N-desmethyl Enzalutamide which is similar to parent form.  Enzamide  exhibits an

XTANDI 40MG Xtandi 40mg  is a non steroidal anti-androgen drug; by inhibiting the androgen synthesis and expels anti-neoplastic activity against prostate tumor. Xtandi 40mg is an oral tablet form, which is endorsed by FDA. Enzalutamide is related with a reducing rate of serum enzyme increased during treatment, be that as it may, have not been connected to instances of clinically clear liver damage with jaundice. Xtandi 40mg Tablet Enzalutamide Mechanism of action Androgen is a male hormone; testosterone is a one of the hormone secreted from androgen which is responsible for growth of the tumor cells present in the prostate glands. Xtandi 40 mg tablets are comprises of  Enzalutamide  which acts by inhibiting the binding of androgen into androgen receptor site. This inhibition leads to interfere with signal transduction of receptors and causes growth retardation. The active metabolite of Enzalutamide is N-desmethyl Enzalutamide which is similar to parent form. Xtandi e